PMID: 11604568Oct 18, 2001Paper

Acute bleeding complications in patients after bone marrow transplantation

Current Opinion in Hematology
S Nevo, G B Vogelsang

Abstract

Acute bleeding is a frequent complication that commonly associates with increased morbidity after bone marrow transplantation. Except for diffuse alveolar hemorrhage and cerebral hemorrhage, bleeding is infrequently recorded as a direct cause of death. Yet outcome analyses showed that bleeding from any reviewed site was associated with reduced survival. Reduced survival was correlated with bleeding intensity and the number of bleeding sites. These data point to the need to monitor all manifestations of bleeding, as bleeding may identify patients at risk for bone marrow transplantation toxicity. Until recently, prophylactic platelet transfusions were commonly given at a trigger of 20 x 10(9)/L. Whereas bleeding is more likely to occur when platelet counts drop to low levels, most bleeding episodes were recorded with platelet counts greater than 20 x 10(9)/L, suggesting causes other than profound thrombocytopenia in the pathogenesis of bleeding. Given that a trigger of 10 x 10(9)/L has become accepted for prophylactic platelet transfusions, care should be taken to ensure that parameters other than the incidence of bleeding have not been adversely affected.

References

Feb 4, 1978·Lancet·J SolomonE Beutel
Feb 1, 1992·La Clinica terapeutica·T R Rogers
Feb 1, 1992·Mayo Clinic Proceedings·L LetendreM A Gertz
Nov 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J D ShepherdG L Phillips
Feb 1, 1991·The American Journal of Medicine·A Agostoni, M Cicardi
Feb 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L BrugieresJ Lemerle
Nov 1, 1989·The American Journal of Medicine·R A RobbinsW P Vaughan
Apr 3, 1987·JAMA : the Journal of the American Medical Association
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A BediR J Jones
Sep 1, 1994·Urology·C C YangD G Assimos
Feb 1, 1994·Journal of Neurology·S PomeranzR Or
Jul 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M VoseJ O Armitage
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K D HeckmanC P Burns
Mar 7, 1998·Acta Haematologica·M GlazerR Or
Feb 26, 1999·Bone Marrow Transplantation·A SeberN Ramsay
Sep 22, 1999·Bone Marrow Transplantation·A IguchiY Ishikawa
Nov 5, 1999·Current Opinion in Hematology·H M RinderE L Snyder
Mar 14, 2000·Bone Marrow Transplantation·M ColosimoS Durrant
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A SchifferUNKNOWN American Society of Clinical Oncology

❮ Previous
Next ❯

Citations

Mar 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C-Y ChenH-F Tien
Mar 31, 2015·British Journal of Haematology·Jorge LabradorJose R González-Porras
Sep 4, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Melhem SolhDaniel Weisdorf
May 24, 2003·Leukemia·D J Weisdorf
Aug 3, 2016·European Journal of Gastroenterology & Hepatology·Chaowapong JarasvaraparnSuporn Treepongkaruna

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.